reason report
ep tax rate revenu guidanc updat
bottom line wcg report big ep beat come
driven slightli consensu revenu tax rate beat
consolid larg line slight miss ratio
updat estim rais maintain
ep estim modest chang season
cadenc guidanc updat await anti-trust review
american hospit associ sent concern deal
doj expect follow
beat revenu tax rate ep driven
slightli consensu revenu solid tax rate beat revenu
beat consensu tax rate came
beat consensu exhibit
consolid in-lin consensu consolid
came line consensu medicaid pdp
deterior yoy medicar flat medicaid increas
yoy pdp increas yoy
medicar remain flat yoy cfo ni day
claim payabl improv day compar
exhibit
guidanc updat due pend merger
wcg provid updat financi guidanc also
manag take question confer call
hospit associ sent concern deal doj
expect follow expect transact undergo
lengthi comprehens regulatori review due horizont
natur deal perform initi analysi medicar
overlap within key state deeper look medicaid market
balanc sheet remain solid balanc sheet remain strong
debt capit parent cash end exhibit
estim larg remain maintain
ep estim modest chang season cadenc
revenu estim move
 respect pt contempl price-to-earnings
averag ep exhibit
price-to-earnings average
net debt total capit
price-to-earnings lt ep growth
year price history/av daili volume mil wcg
compani inform svb leerink llc research
revenu mm ex-invest incom
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
wcg report big ep beat come driven slightli consensu revenu
tax rate beat consolid larg line slight miss ratio updat
estim rais maintain ep estim modest chang
season cadenc guidanc updat await anti-trust review american hospit
associ sent concern deal doj expect follow
ep driven slightli consensu revenu solid tax rate beat revenu
beat consensu tax rate came beat consensu
cfo ni day claim payabl improv day compar
wcg report strong quarter beat consensu ep estim higher revenu
wellcar mm except ep reportedsvb revenu premium advantag drug net adjust ep non report wellcar plan inc
dcp declin seq day day flat yoy
membership grew qoq across segment
consolid came line consensu medicaid pdp
deterior yoy medicar flat medicaid increas yoy pdp
increas yoy medicar remain flat yoy
consolid flat yoy medicaid pdp increas yoy
medicaid breakdown total membership total mm advantag total non-gaap metric report wellcar plan inc
due pend merger wcg provid updat financi guidanc also
manag take question confer call
wcg provid updat guidanc
await anti-trust review american hospit associ sent concern deal doj
expect follow expect transact undergo lengthi comprehens regulatori
total revenu rate claim payabl previou reportingwcg compani guidanc decemb guidanc februari leerinkconsensu estim premium revenu premium revenu medicaid premium revenu medicaid premium revenu medicaid medicaid premium revenu pdp premium revenu pdp incom sg expens depreci amort effect incom tax wellcar plan inc
review due horizont natur deal perform initi analysi medicar overlap within
key state deeper look medicaid market fl
medicar believ lower bar level market share would alert regul
perform proprietari analysi show top ten market combin entiti would
outsiz share market exceed market share limit cnc/wcg
divest member requir lower market share mark state would result total
divestitur member revenu assum per member per month pmpm
medicaid believ bar higher medicaid plan price taker marketplac
still believ regul take close look heavi wellcar medicaid market fl il ga mi ky ny
exhibit pull statist medicaid enrol region fl exampl identifi six
region fl would exceed mark wcg/cnc divest member mark
region total would sum member premium revenu
analysi identifi roughli market market share mark close
scrutin market combin entiti market share wellcar plan inc
analysi identifi roughli region fl market share mark close
florida agenc health administr
total estim divestitur fl market revenu
balanc sheet solid debt cap parent cash
wcg debt cap
maintain ep estim modest chang season cadenc
revenu estim move respect
pt contempl price-to-earnings averag ep
maintain ep estim
debt capconsensussvb leerinkconsensussvb leerinkconsensussvb leerinkrevenu net incom bp wellcar plan inc
wcg trade price-to-earnings consensu ep pt contempl price-to-earnings
averag ep
mm except revenu exc invest expensesmed premium oper adjust pdp wellcar plan inc
ssi abd icaid icar wellcar plan inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
pt contempl price-to-earnings averag ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base absolut price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
price target base price-to-earnings averag ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
integr regulatori risk across merg ci esrx
pt contempl price-to-earnings averag ep
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
pt contempl price-to-earnings consensu price-to-earnings
ep
underwrit risk aet asset trade peak margin commerci fulli
insur though medacorp commerci broker price survey give us confid
price environ remain appropri hard offer flat even potenti
modestli expand underwrit margin risk potenti futur margin compress
aet health insur even meaning given associ neg impact
debt ebitda load compani need focus debt
pay next month departur shawn guertin aet cfo
slate becom cfo make us less confid price postur
health insur book commenc new bulk compet
share gain commerci medicar advantag market
macroeconom risk risk macroeconom downturn higher
defens pbm sub sector given cyclic correl retail front store
sale employ data
regulatori risk convinc pbm add valu earn
low probabl threat potenti drug manufactur rebat elimin off-set
new busi model includ administr fee and/or perform guarante
expos pbm retail pharmaci busi compar
player pbm risk
execut integr risk face greater risk well given integr
pbm broader organ also transform agenda around
build retail front model amid risk leverag balanc sheet
e-commerce/amzn greater exposur eros sale on-line
channel well given exposur retail front store retail pharmaci e-
commerc though larg price retail multipl expect less like
pursu agenda becom pbm given associ integr clinic evid
base treatment guidelin integr provid network domin captiv pbm
model mega deal
remain posit reiter op rate month pt
contempl price-to-earnings averag ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost trend
util improv economi servic arena yet yield adequ
return capit
sotp valuat point per share expect premium toward much
potenti takeout price per share see like buyer light
synergi medicaid complet pbm across ingeniorx optum rx
optum rx seek specialti rx expect look region player shore
medicaid pois well build third-parti servic platform best
place well pay cash also like interest given medicaid focu strategi
bring pbm in-hous would like pay asset equiti rather cash
delev fide transact financi buyer also like suitabl strateg
buyer identifi
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
pt contempl multipl averag
ep may day dive top-lin growth continu margin expans
 strategi may import posit catalyst
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
averag cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
averag ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
